Bernard L. Kasten, Director at CLEVELAND BIOLABS INC (CBLI), bought 10,000 shares at $2.60 ($26K) on 2011-08-15, disclosed to the SEC on 2011-08-15.
Open-market purchase of $26k CBLI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.58 | 5,000 | $13K | 49.8% |
| 2 | $2.60 | 5,000 | $13K | 50.2% |
| Total | $2.59 avg | 10,000 | $26K | 100% |
| Filing → |
| CBLI | BUY | 2010-11-22 | $74K | — | Filing → |